Abstract
Excluding hemangiomas, germ cell tumors (GCTs) are the most common neoplasm in neonates, comprising a wide range of benign and malignant tumors with unique histological diversity. Although these tumors are relatively rare, antenatal ultrasonography has increased their detection before birth. Extragonadal GCTs (EGCTs) are the most common GCTs in neonates, with sacrococcygeal teratomas (SCTs) being the most prevalent EGCTs. SCTs are characterized as protruding masses arising from the sacrococcygeal region with or without variable extension into the presacral space. Patients with SCTs typically have an excellent prognosis, though this is dependent on the ease of surgical resection, the timing of diagnosis, and the malignant potential of the tumor. Whereas some GCTs can be diagnosed and treated prenatally, this review focuses on postnatal management of GCTs. We explore the embryological development, histopathology, biomarkers, clinical presentation, diagnostic features, and treatment of neonatal GCTs. Because the overall prognosis is excellent for the majority of patients with GCTs, we also discuss the potential long-term effects of antineoplastic agents used to treat patients with malignant disease.
Keywords: Choriocarcinoma, embryonal carcinoma, germinoma, neonatal germ cell tumors, postnatal neoplasm, teratoma, yolk sac tumor.
Current Pediatric Reviews
Title:Neonatal Germ Cell Tumors
Volume: 11 Issue: 3
Author(s): John A. Sandoval and Regan F. Williams
Affiliation:
Keywords: Choriocarcinoma, embryonal carcinoma, germinoma, neonatal germ cell tumors, postnatal neoplasm, teratoma, yolk sac tumor.
Abstract: Excluding hemangiomas, germ cell tumors (GCTs) are the most common neoplasm in neonates, comprising a wide range of benign and malignant tumors with unique histological diversity. Although these tumors are relatively rare, antenatal ultrasonography has increased their detection before birth. Extragonadal GCTs (EGCTs) are the most common GCTs in neonates, with sacrococcygeal teratomas (SCTs) being the most prevalent EGCTs. SCTs are characterized as protruding masses arising from the sacrococcygeal region with or without variable extension into the presacral space. Patients with SCTs typically have an excellent prognosis, though this is dependent on the ease of surgical resection, the timing of diagnosis, and the malignant potential of the tumor. Whereas some GCTs can be diagnosed and treated prenatally, this review focuses on postnatal management of GCTs. We explore the embryological development, histopathology, biomarkers, clinical presentation, diagnostic features, and treatment of neonatal GCTs. Because the overall prognosis is excellent for the majority of patients with GCTs, we also discuss the potential long-term effects of antineoplastic agents used to treat patients with malignant disease.
Export Options
About this article
Cite this article as:
A. Sandoval John and F. Williams Regan, Neonatal Germ Cell Tumors, Current Pediatric Reviews 2015; 11 (3) . https://dx.doi.org/10.2174/1573396311666150714105531
DOI https://dx.doi.org/10.2174/1573396311666150714105531 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phosphorylation Processes Controlling Aromatase Activity in Br east Cancer: An Update
Mini-Reviews in Medicinal Chemistry Angiogenesis Markers in Gynecological Tumors and Patents for Anti- Angiogenic Approach: Review
Recent Patents on Anti-Cancer Drug Discovery The Carnitine Transporter Network: Interactions with Drugs
Current Chemical Biology Blockade of Neoangiogenesis, a New and Promising Technique to Control the Growth of Malignant Tumors and their Metastases
Current Vascular Pharmacology Damage and Recovery of the Bone Marrow Microenvironment Induced by Cancer Chemotherapy – Potential Regulatory Role of Chemokine CXCL12/Receptor CXCR4 Signalling
Current Molecular Medicine DNA Drug Design for Cancer Therapy
Current Pharmaceutical Design Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy
Current Pharmaceutical Design Sex Hormones and their Analogues in Neuroimmune Biology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) MicroRNA in Cervical Carcinogenesis: Window of Therapeutic Potential
Current Women`s Health Reviews Natural Products Based Anticancer Agents
Mini-Reviews in Organic Chemistry HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
Current Molecular Medicine Advances of Phenoxazines: Synthesis, Reactivity and Their Medicinal Applications
Current Medicinal Chemistry Life and Death in the Placenta: New Peptides and Genes Regulating Human Syncytiotrophoblast and Extravillous Cytotrophoblast Lineage Formation and Renewal
Current Protein & Peptide Science Hypoxic Culture Conditions for Mesenchymal Stromal/Stem Cells from Wharton’s Jelly: A Critical Parameter to Consider in a Therapeutic Context
Current Stem Cell Research & Therapy Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Development of A Novel System Based on Green Magnetic / Graphene Oxide / Chitosan /Allium Sativum / Quercus / Nanocomposite for Targeted Release of Doxorubicin Anti-Cancer Drug
Anti-Cancer Agents in Medicinal Chemistry Killing Glioma ‘Stem-like’ Cells via Drug-Induced Relocation of Endosomal Urokinase Proteins
Anti-Cancer Agents in Medicinal Chemistry Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects
Current Medicinal Chemistry Challenges in Managing Amniotic Fluid Embolism: An Up-to-Date Perspective on Diagnostic Testing with Focus on Novel Biomarkers and Avenues for Future Research
Current Pharmaceutical Biotechnology